Trial Profile
Tolvaptan and Conventional Treatment for Acute Decompensated Heart Failure
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary) ; Furosemide
- Indications Acute heart failure; Decompensated heart failure
- Focus Therapeutic Use
- 02 Jul 2015 New trial record